In this study, it was assumed that using the auto-reduction of the hydroquinone adjacent to the quinone on doxorubicin was a sufficient indicator of the rate of oxidation of a potential redox cycle, either on the hydroquinone or the quinone after reduction
Based on the importance of identifying biochemical correlates, this study investigated GSH levels, CD4 and CD8 lymphocyte counts, and their associations with perceived stress, anxiety and depression symptoms, self-esteem, and socio-familiar support in young adults without a prior clinical diagnosis
Caffeic acid, a dietary polyphenol, as a promising candidate for combination therapy

The phosphocholine head group in phospholipids of normal healthy cell membranes is not accessible but, when cells are damaged and die, enhanced availability of lysophosphatidylcholine and disruption of the lipid bilayer expose phosphocholine residues to which CRP avidly binds ( In acute respiratory distress syndrome (ARDS), there is extensive overproduction of free radicals and reduced extracellular and intracellular GSH leading to oxidative cell damage ( Glutathione is an important antioxidant in the lungs, but its concentration is low in the airways of patients with cystic fibrosis, since GSH is transported into the airways by the cystic fibrosis transmembrane conductance regulator, which is mutated in cystic fibrosis patients ( An oxidant/antioxidant imbalance characterized by oxidative stress and low GSH levels is involved in the pathogenesis of idiopathic pulmonary fibrosis, since data show marked GSH deficiency in the lower respiratory tract of those patients ( via the airways may be a novel therapeutic strategy for the treatment of idiopathic pulmonary fibrosis ( Glutathione and atherosclerosis Cardiovascular diseases are the leading causes of death in the US compared to any other cause (151), suggesting that a specific antioxidant/prooxidant imbalance, characterized by a weak GSH-related enzymatic antioxidant shield present in human atherosclerotic lesions, may be involved in atherogenic processes in humans (152)
